Gapping up
In reaction to strong earnings/guidance: n/a.
In the news: PSDV +11% (plans to file for EU marketing approval of Medidur, for chronic non-infectious uveitis of the posterior segment of the eye), BSI +7.5% (annoounces appointment of Tzachi Otsar as director effective immediately; Dan Weiss resigns as director), ROVI +3.4% (following last week's ~50% move higher), SUNE +3% (SunEdison provides December business update: Successfully renegotiated the Vivint Solar (VSLR) acquisition; key assumptions include EBITDA of $1.186 bln), EOX +2.5% (discloses Angelus will acquire a portion of the Company's undeveloped leaseholds in Montana and North Dakota for ~$9.75 mln), WTW +2.2% (still checking), REXI +2% (after last week's boost from Leon G. Cooperman stake), PN +2% (continued strength), PSEC +1.2% (insider buy disclosures), AIXG +1.1% (still checking), FIT +1% (Fitbit's iOS app jumps to number one on Apple's top downloaded list over Christmas holiday), QCOM +0.9% (Qualcomm enters into a Chinese Patent License Agreement with QiKu Internet Network Scientific, a JV between Qihu and Coolpad), SIG +0.8% (positive Barron's mention; The WSJ's Heard on the Street column out positive on Signet),NPTN +0.8% (after last Thursday's 10% move higher), DIS +0.6% (The Force Awakens sets record as fastest movie to surpass $1 bln in worldwide box office sales ), ATNM +0.4% (ticking higher; Actinum Pharma and Memorial Sloan Kettering Cancer Center sign an agreement regarding donated common shares).